chr15-90638781-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022769.5(CRTC3):āc.1514A>Gā(p.Gln505Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000096 in 1,614,078 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022769.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRTC3 | NM_022769.5 | c.1514A>G | p.Gln505Arg | missense_variant | 13/15 | ENST00000268184.11 | NP_073606.3 | |
CRTC3 | NM_001042574.3 | c.1514A>G | p.Gln505Arg | missense_variant | 13/15 | NP_001036039.1 | ||
CRTC3-AS1 | NR_120372.1 | n.509+2261T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRTC3 | ENST00000268184.11 | c.1514A>G | p.Gln505Arg | missense_variant | 13/15 | 1 | NM_022769.5 | ENSP00000268184.6 | ||
CRTC3 | ENST00000420329.6 | c.1514A>G | p.Gln505Arg | missense_variant | 13/15 | 2 | ENSP00000416573.2 | |||
CRTC3 | ENST00000686240.1 | n.*927A>G | non_coding_transcript_exon_variant | 12/14 | ENSP00000508866.1 | |||||
CRTC3 | ENST00000691029.1 | n.1514A>G | non_coding_transcript_exon_variant | 13/17 | ENSP00000510507.1 | |||||
CRTC3 | ENST00000692149.1 | n.*841A>G | non_coding_transcript_exon_variant | 11/13 | ENSP00000510448.1 | |||||
CRTC3 | ENST00000686240.1 | n.*927A>G | 3_prime_UTR_variant | 12/14 | ENSP00000508866.1 | |||||
CRTC3 | ENST00000692149.1 | n.*841A>G | 3_prime_UTR_variant | 11/13 | ENSP00000510448.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152196Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251484Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135920
GnomAD4 exome AF: 0.0000992 AC: 145AN: 1461882Hom.: 1 Cov.: 32 AF XY: 0.000107 AC XY: 78AN XY: 727238
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152196Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2024 | The c.1514A>G (p.Q505R) alteration is located in exon 13 (coding exon 13) of the CRTC3 gene. This alteration results from a A to G substitution at nucleotide position 1514, causing the glutamine (Q) at amino acid position 505 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at